All Articles

When a superstorm threatened a 10,000-person conference, one firm's crisis response offered a masterclass in resilience with lessons for the entire industry.

Anixa Biosciences now fully controls its breast cancer vaccine after promising Phase 1 data. What does this strategic move mean for investors and medicine?

Odysight.ai's new sensors offer a live video feed from inside hot, oil-filled machinery, a breakthrough poised to transform industrial predictive maintenance.

A Minneapolis firm is testing a graft that helps the body rebuild its own arteries. This could end a painful, risky part of traditional heart bypass surgery.

As cargo theft surges, one company’s AI-powered security is becoming the new standard for protecting the nation’s vital logistics and its drivers.

With three major awards, NanaWall's new glass system reveals how deep engineering and market foresight are reshaping the value of architectural components.

The rise of independent 'Operator' models is untethering top earners from the city core, fueling a new wave of demand for luxury lifestyle communities.

An Indiana biotech prepares for biotech's biggest stage, showcasing a pipeline that offers new hope for chronic endocrine and metabolic disorders.

This new partnership is more than a sponsorship. It's a strategic move to close the gender data gap in sports science and redefine athlete care for women.

Premier Equipment's latest acquisition signals a major shift in NC's dealership landscape, ending a 60-year legacy and building a new regional giant.

L'OFFICIEL's historic show at the London Stock Exchange isn't just about style; it's a strategic play where cultural capital meets financial markets.

Cerro de Pasco Resources locks in a vital community deal in Peru, a key step in a $400M plan to turn a century of mining waste into a profitable venture.

Rail Vision just secured a key European patent for its AI collision avoidance tech. Is this IP fortress enough to challenge giants and define the future of rail?

Beyond the factory, China's manufacturers are now tech pioneers. The MEI Awards reveal a strategic shift that is reshaping global markets and supply chains.

AMTD Digital's subsidiary is on a global hotel buying binge, but a history of extreme stock volatility and underlying financial risks raise serious questions.

A new FDA clearance for its AI software enhances Hyperfine's portable MRI, positioning it to disrupt the lucrative stroke diagnostics market. Here's why.

After a NYSE delisting, FOXO Technologies is betting big on healthcare acquisitions. Is this a savvy turnaround or a high-risk gamble for investors?

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

The hiring of M&A veteran Eric Olson as Chief Corporate Development Officer signals REI Systems’ aggressive new strategy to conquer the national security market.